Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Logo

Fraunhofer-Institut Biomedizinische Technik


The Fraunhofer Institute for Biomedical Engineering IBMT has worked as a partner of industry since 1987, seeking solutions to specific tasks in the fields of medical technology, medical telematics, materials testing technology, in building, safety and air-conditioning technology, as well as in industrial process automation and inline/online process monitoring, particularly for the food-processing, chemical and pharmaceutical industries.

The Institute supports technology transfer in the medical field and in other sectors of industry. Minimally invasive and non-invasive techniques, robot-assisted surgery, miniaturization, the coupling of technical and biological microsystems, biocompatibility, ultrasound technology, computer-based simulation, sensor technology in manufacturing, magnetic resonance, continuous measurement, telemetric data and energy transfer, medical telematics and multi-local sensor systems linked to communications systems, all represent key areas of the Institute´s activities.

Spin-off companies from the Fraunhofer IBMT are able to carry out sensor and system production on demand, allowing the institute to fulfil customer requirements with the lowest possible time-to-market. In 1997, the European Center of Competence for Biomedical Microdevices was set up at the Sulzbach / Saar location of the Fraunhofer IBMT. A further component of the Fraunhofer IBMT network is the Fraunhofer IBMT Technology Center Shenzhen, China, established in 1999 and now working to develop contacts and partnerships with regional government authorities and industry in China. The Fraunhofer IBMT Technology Center Hialeah, founded in 1996 and focusing on actuators, microactuators and complex systems / microsystems, has given the Fraunhofer IBMT a foothold in the US market.

In November 1998, the working group on Molecular Bioanalysis was set up in Potsdam-Rehbrücke as a further external activity of the Fraunhofer IBMT. Its objective is development of in-situ analysis systems for inexpensive diagnosis and therapy control, and for environmental monitoring. The IBMT is a founding member of the Fraunhofer Alliance Life Sciences, created in September 2001.


 

Fraunhofer-Institut Biomedizinische Technik
IBMT

Press releases

Range of products

Further information: http://www.ibmt.fhg.de/